In a rigorous 12-month trial, Tai Chi significantly reduced blood pressure in prehypertensive adults compared to equivalent aerobic exercise. As complementary medicine, meditative modalities like Tai Chi could provide drug-free alternatives for preventing heart disease and related risks.  

A new study in JAMA Network Open compared Tai Chi against standard aerobic exercise for improving heart health biomarkers in patients with prehypertension.1 Prehypertension raises cardiovascular disease odds by 65% compared to normal blood pressure.2 Early intervention can prevent progression to hypertension and associated arterial stiffening tied to stroke.3 While physical activity is first-line therapy, clear evidence on optimal modalities is lacking.  

This prospective Chinese trial enrolled 342 sedentary adults aged 18-65 with elevated blood pressure. Patients were randomized into two hour-long sessions weekly of either Tai Chi—a mind-body practice combining yogic postures, breathing, and meditation—or moderate-intensity aerobic activity like brisk walking. After each 12-month regimen, subjects’ blood pressure was tracked via office and 24-hour ambulatory monitoring.   

Tai Chi decreased blood pressure significantly more than aerobics, lowering systolic blood pressure (the heart contracting) by over 7 points versus 4.6 points for exercise alone. Effects were most dramatic at night, indicating Tai Chi’s stress-relieving effects may restrain blood pressure when most vulnerable.  

Though relaxing, Tai Chi provides activity equivalent to moderate exercise, boosting strength and flexibility. This and related mind-body arts could offer safe, appealing activity options for those unable or unwilling to perform conventional aerobic training. Results support integrative health policies validating traditional healing modalities through scientific evidence.

To explore more evidence-based natural approaches to hypertension, view our database on the subject here.

Explore more research on the therapeutic properties of Tai Chi here.

References  

1. Li X, et al. JAMA Netw Open. 2024;7(2):e2354937.  

2. Han M, et al. J Hypertens. 2019;37(12):2325-2332. 

3. Bajpai JK, et al. J Clin Diagn Res. 2014;8(4):BC07-BC10.